Akt activation confers an inferior survival in patients with activated B-cell subtype of diffuse large B-cell lymphoma: a report from The International DLBCL Rituximab-CHOP Consortium Program

Qi Shen; Zijun Y Xu-Monette; Ganiraju C Manyam; Carlo Visco; Alexander Tzankov; Xin Cao; Lijuan Deng; Santiago Montes-Moreno; Karen Dybkær; April Chiu; Attilio Orazi; Youli Zu; Govind Bhagat; Kristy L Richards; Eric D. Hsi; William W L Choi; J Han van Krieken; Jooryung Huh; Maurilio Ponzoni; Andrés J M Ferreri; John P Farnen; Michael B. Møller; Jane N. Winter; Miguel A. Piris; L Jeffrey Medeiros; Ken H Young

doi:10.1016/j.clml.2015.04.096

Akt activation confers an inferior survival in patients with activated B-cell subtype of diffuse large B-cell lymphoma: a report from The International DLBCL Rituximab-CHOP Consortium Program

Qi Shen, Zijun Y Xu-Monette, Ganiraju C Manyam, Carlo Visco, Alexander Tzankov, Xin Cao, Lijuan Deng, Santiago Montes-Moreno, Karen Dybkær, April Chiu, Attilio Orazi, Youli Zu, Govind Bhagat, Kristy L Richards, Eric D. Hsi, William W L Choi, J Han van Krieken, Jooryung Huh, Maurilio Ponzoni, Andrés J M FerreriJohn P Farnen, Michael B. Møller, Jane N. Winter, Miguel A. Piris, L Jeffrey Medeiros, Ken H Young

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

Original language	English
Article number	511
Journal	Clinical Lymphoma, Myeloma & Leukemia
Volume	15
Issue number	Suppl. 1
Pages (from-to)	S220
Number of pages	1
ISSN	2152-2650
DOIs	https://doi.org/10.1016/j.clml.2015.04.096
Publication status	Published - 2015
Event	Annual Meeting of the Society of Hematologic Oncology - Houston, United States Duration: 17 Sept 2014 → 20 Sept 2014 Conference number: 2

Conference

Conference	Annual Meeting of the Society of Hematologic Oncology
Number	2
Country/Territory	United States
City	Houston
Period	17/09/2014 → 20/09/2014

Access to Document

10.1016/j.clml.2015.04.096

http://www.sciencedirect.com/science/article/pii/S2152265015002542

AUB Link

Search for the material in Aalborg University Library's search engine

Cite this

Shen, Q., Xu-Monette, Z. Y., Manyam, G. C., Visco, C., Tzankov, A., Cao, X., Deng, L., Montes-Moreno, S., Dybkær, K., Chiu, A., Orazi, A., Zu, Y., Bhagat, G., Richards, K. L., Hsi, E. D., Choi, W. W. L., Han van Krieken, J., Huh, J., Ponzoni, M., ... Young, K. H. (2015). Akt activation confers an inferior survival in patients with activated B-cell subtype of diffuse large B-cell lymphoma: a report from The International DLBCL Rituximab-CHOP Consortium Program . Clinical Lymphoma, Myeloma & Leukemia, 15(Suppl. 1), S220. Article 511. https://doi.org/10.1016/j.clml.2015.04.096

@article{4c44980708364d13abd1695aefe41d0b,

title = "Akt activation confers an inferior survival in patients with activated B-cell subtype of diffuse large B-cell lymphoma: a report from The International DLBCL Rituximab-CHOP Consortium Program ",

author = "Qi Shen and Xu-Monette, {Zijun Y} and Manyam, {Ganiraju C} and Carlo Visco and Alexander Tzankov and Xin Cao and Lijuan Deng and Santiago Montes-Moreno and Karen Dybk{\ae}r and April Chiu and Attilio Orazi and Youli Zu and Govind Bhagat and Richards, {Kristy L} and Hsi, {Eric D.} and Choi, {William W L} and {Han van Krieken}, J and Jooryung Huh and Maurilio Ponzoni and Ferreri, {Andr{\'e}s J M} and Farnen, {John P} and M{\o}ller, {Michael B.} and Winter, {Jane N.} and Piris, {Miguel A.} and Medeiros, {L Jeffrey} and Young, {Ken H}",

year = "2015",

doi = "10.1016/j.clml.2015.04.096",

language = "English",

volume = "15",

pages = "S220",

journal = "Clinical Lymphoma, Myeloma & Leukemia",

issn = "2152-2650",

publisher = "Elsevier",

number = "Suppl. 1",

note = "Annual Meeting of the Society of Hematologic Oncology ; Conference date: 17-09-2014 Through 20-09-2014",

}

Shen, Q, Xu-Monette, ZY, Manyam, GC, Visco, C, Tzankov, A, Cao, X, Deng, L, Montes-Moreno, S, Dybkær, K, Chiu, A, Orazi, A, Zu, Y, Bhagat, G, Richards, KL, Hsi, ED, Choi, WWL, Han van Krieken, J, Huh, J, Ponzoni, M, Ferreri, AJM, Farnen, JP, Møller, MB, Winter, JN, Piris, MA, Medeiros, LJ & Young, KH 2015, 'Akt activation confers an inferior survival in patients with activated B-cell subtype of diffuse large B-cell lymphoma: a report from The International DLBCL Rituximab-CHOP Consortium Program ', Clinical Lymphoma, Myeloma & Leukemia, vol. 15, no. Suppl. 1, 511, pp. S220. https://doi.org/10.1016/j.clml.2015.04.096

Akt activation confers an inferior survival in patients with activated B-cell subtype of diffuse large B-cell lymphoma: a report from The International DLBCL Rituximab-CHOP Consortium Program . / Shen, Qi; Xu-Monette, Zijun Y; Manyam, Ganiraju C et al.
In: Clinical Lymphoma, Myeloma & Leukemia, Vol. 15, No. Suppl. 1, 511, 2015, p. S220.

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

TY - ABST

T1 - Akt activation confers an inferior survival in patients with activated B-cell subtype of diffuse large B-cell lymphoma

T2 - Annual Meeting of the Society of Hematologic Oncology

AU - Shen, Qi

AU - Xu-Monette, Zijun Y

AU - Manyam, Ganiraju C

AU - Visco, Carlo

AU - Tzankov, Alexander

AU - Cao, Xin

AU - Deng, Lijuan

AU - Montes-Moreno, Santiago

AU - Dybkær, Karen

AU - Chiu, April

AU - Orazi, Attilio

AU - Zu, Youli

AU - Bhagat, Govind

AU - Richards, Kristy L

AU - Hsi, Eric D.

AU - Choi, William W L

AU - Han van Krieken, J

AU - Huh, Jooryung

AU - Ponzoni, Maurilio

AU - Ferreri, Andrés J M

AU - Farnen, John P

AU - Møller, Michael B.

AU - Winter, Jane N.

AU - Piris, Miguel A.

AU - Medeiros, L Jeffrey

AU - Young, Ken H

N1 - Conference code: 2

PY - 2015

Y1 - 2015

U2 - 10.1016/j.clml.2015.04.096

DO - 10.1016/j.clml.2015.04.096

M3 - Conference abstract in journal

SN - 2152-2650

VL - 15

SP - S220

JO - Clinical Lymphoma, Myeloma & Leukemia

JF - Clinical Lymphoma, Myeloma & Leukemia

IS - Suppl. 1

M1 - 511

Y2 - 17 September 2014 through 20 September 2014

ER -